Michigan life sciences maker to spend $160 million on expansion

Welcome to Thomas Insights – every day we post the latest news and analysis to keep our readers up to date with what’s happening in the industry. Sign up here to get the day’s top stories straight to your inbox.

Life Sciences Manufacturer Grand River Aseptic Manufacturing (GRAM) announcement it would invest $160 million in expanding its fill and finish facilities. The Grand Rapids-based company will also receive $120 million in US government contracts to support development.

Multi-year contracts are with the US Department of Defense and the US Department of Health and Human Services.

The agreement supports the construction of the second floor of an 80,000 square foot aseptic filling facility. He will also contribute to the 30,000 square foot expansion of a 200,000 square foot finishing center, which will include a sterility laboratory and additional storage space.

GRAM’s filling capacity will increase to four insulator filling lines as a result of the contracts. It will also contribute to the advancement of the company’s operations through state-of-the-art technology and equipment.

The company’s facilities and equipment allow GRAM to contract manufacturing for pharmaceutical companies and the US government. GRAM previously participated in “Operation Warp Speed” and provided fill-and-finish services to manufacture a COVID-19 vaccine.

Image Credit: Grand River Aseptic Manufacturing

American Snack Company to create 800 jobs in Georgia as part of its expansion Next story »

More trade and industry

Previous W&T Offshore announces the retirement of Steve L. Schroeder and
Next Machine builder makes intricate cuts with Spyral saw blades